Neuropharmacology & Neurotherapeutics
Rotigotine
Jul. 29, 2021
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Percentage of patients who carried an FGF14 (GAA) 250 or greater repeat expansion in the subgroups with (1) cerebellar ataxia plus polyneuropathy (CA+PN) (5 of 13 patients), (2) cerebellar ataxia plus bilateral vestibulopathy (CA+BVP) (9 of 21), and (3) cerebellar ataxia plus polyneuropathy and bilateral vestibulopathy (CA+PN+ BVP) (3 of 11). (Source: Pellerin D, Wilke C, Traschütz A, et al. Intronic FGF14 GAA repeat expansions are a common cause of ataxia syndromes with neuropathy and bilateral vestibulopathy. J Neurol Neurosurg Psychiatry 2024;95[2]:175-179. Creative Commons Attribution 4.0 International [CC BY 4.0] license, creativecommons.org/licenses/by/4.0.)